Brandes International ETF (BINV) News
Follow Brandes International ETF (BINV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
B Investments Holding board approves 53.5% stake acquisition in BIG Investment Group
MNA | Sep 16, 2026, 08:06 AM UTC
L
BioInvent International to Present at Investing in Life Science on September 22
The 4th edition of Investing in Life Science takes place on September 22 in Stockholm. Björn Frendéus, CSO will present BioInvent International to specialist life science investors and potential strategic partners.Invest
EQUITY | Sep 10, 2026, 07:00 AM UTC
L
BioInvent (Q2 Review): A Quarter of Positive Clinical Read-Outs
Redeye’s analyst just published a Research Update on BioInvent.Click here to read the articleMake sure to add BioInvent to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding
EQUITY | Sep 01, 2026, 03:55 PM UTC
M
BioInvent Q2 net sales fall as loss widens
BioInvent reported Q2 net sales drop and a widening loss.
EQUITY | Aug 27, 2026, 06:09 AM UTC
L
BINV: Clinical advances for BI-1808 and BI-1206 contrast with a sharp revenue drop and financing risks
BINV: Clinical advances for BI-1808 and BI-1206 contrast with a sharp revenue drop and financing risks
EQUITY | Aug 27, 2026, 06:02 AM UTC
L
BioInvent International AB interim report covers Jan–June 2026
BioInvent International AB published its interim report for January–June 2026.
EQUITY | Aug 27, 2026, 06:01 AM UTC
L
BioInvent publishes preclinical manuscript on BI-1808, BI-1910
BioInvent (BINV) announces the publication of a preclinical manuscript covering BI-1808 and BI-1910 in Cancer Research; no catalyst, data, or results were supplied.
EQUITY | Aug 20, 2026, 12:15 PM UTC